FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2406393390> ?p ?o ?g. }

• W2406393390 endingPage "24" @default.
• W2406393390 startingPage "3118" @default.
• W2406393390 abstract "Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized health problem. Various treatment strategies such as thiazolidinediones, metformin, lipid-lowering agents and antioxidants have been evaluated. So far, no single intervention has convincingly improved liver histology. Experience of using silymarin alone or in combination with other agents in patients with NAFLD is limited in the medical literature. The present study was conducted to evaluate the efficacy of silymarin plus vitamin E in the treatment of NAFLD.A sample of 36 patients was enrolled. The diagnosis of NAFLD was confirmed by percutaneous liver biopsy. All patients were randomized to one of the following intervention groups: group I: treated with 2 tablets per day of silymarin plus vitamin E (Eurosil 85®, MEDAS SL) and a lifestyle modification program consisting of hypocaloric diet (1520 kcal, 52% of carbohydrates, 25% of lipids and 23% of proteins) and exercise for 3 months and group II (only with the hypocaloric diet). Anthropometric variables as waist circumference, weight, body mass index (BMI) were measured. Biochemical parameters: Glucose, triglycerides, AST, ALT, GGt levels and insulin resistance (HOMA-IR) were determined under fasting conditions. Non-invasive NAFLD-index were applied before and after the treatments: Fatty liver index (FLI), liver accumulation product (LAP) and NAFLD-Fibrosis score (FS).The mean age was 47.4 ± 11.2 years old (range 18-67); 22 men and 14 women. In group I, 11 patients (61%) have a NAS-score > 5 and 10 (55.5%) in the group II (NS). Anthropometric parameters decreased after treatment in both groups. Patients in both groups showed a decrease in GGt levels after treatment (group I: 68 IU/L vs. 46.2 ± 27 IU/L; p < 0.05 and group II 80.5 ± 46 IU/L vs. 50.3 ± 27 IU/L; p < 0.05). Only in group II we observed a significant decrease in AST and ALT levels. In both groups, we observed a decrease in: FLI index (group I: 86.2 ± 19 vs. 76.9 + 20; p < 0.05 and in group II: 85.2 ± 18 vs. 77.5 ± 23; p < 0.05), and NAFLD-FS index (group I: -1.6 ± 1.8 vs. -2.1 ± 1.5; p < 0.05 and in group II -1 ± 1.9 vs. -1.5 ± 2.1; p < 0.05). Patients in group I who did not get a 5% loss of weight also displayed decreased GGt levels, and in the FLI and NAFLD-FS indexes; whereas patients in group II without decrease of 5% by weight showed no improvement in any of the analyzed parameters.Treatment with silymarin plus vitamin E and a hypocaloric diet ameliorate function hepatic test, and non-invasive NAFLD index. Silymarin can be an alternative valid therapeutic option particularly when other drugs are not indicated or have failed or as a complementary treatment associated with other therapeutic programs." @default.
• W2406393390 created "2016-06-24" @default.
• W2406393390 creator A5006133815 @default.
• W2406393390 creator A5007905745 @default.
• W2406393390 creator A5029938660 @default.
• W2406393390 creator A5057765317 @default.
• W2406393390 creator A5058216219 @default.
• W2406393390 creator A5073924341 @default.
• W2406393390 creator A5079751563 @default.
• W2406393390 creator A5086132711 @default.
• W2406393390 creator A5088656392 @default.
• W2406393390 date "2015-08-01" @default.
• W2406393390 modified "2023-10-11" @default.
• W2406393390 title "Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study." @default.
• W2406393390 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26367736" @default.
• W2406393390 hasPublicationYear "2015" @default.
• W2406393390 type Work @default.
• W2406393390 sameAs 2406393390 @default.
• W2406393390 citedByCount "31" @default.
• W2406393390 countsByYear W24063933902016 @default.
• W2406393390 countsByYear W24063933902017 @default.
• W2406393390 countsByYear W24063933902018 @default.
• W2406393390 countsByYear W24063933902019 @default.
• W2406393390 countsByYear W24063933902020 @default.
• W2406393390 countsByYear W24063933902021 @default.
• W2406393390 countsByYear W24063933902022 @default.
• W2406393390 countsByYear W24063933902023 @default.
• W2406393390 crossrefType "journal-article" @default.
• W2406393390 hasAuthorship W2406393390A5006133815 @default.
• W2406393390 hasAuthorship W2406393390A5007905745 @default.
• W2406393390 hasAuthorship W2406393390A5029938660 @default.
• W2406393390 hasAuthorship W2406393390A5057765317 @default.
• W2406393390 hasAuthorship W2406393390A5058216219 @default.
• W2406393390 hasAuthorship W2406393390A5073924341 @default.
• W2406393390 hasAuthorship W2406393390A5079751563 @default.
• W2406393390 hasAuthorship W2406393390A5086132711 @default.
• W2406393390 hasAuthorship W2406393390A5088656392 @default.
• W2406393390 hasConcept C126322002 @default.
• W2406393390 hasConcept C2775934546 @default.
• W2406393390 hasConcept C2777391703 @default.
• W2406393390 hasConcept C2777766500 @default.
• W2406393390 hasConcept C2778163477 @default.
• W2406393390 hasConcept C2778270857 @default.
• W2406393390 hasConcept C2778772119 @default.
• W2406393390 hasConcept C2779134260 @default.
• W2406393390 hasConcept C2779306644 @default.
• W2406393390 hasConcept C2780221984 @default.
• W2406393390 hasConcept C2780323712 @default.
• W2406393390 hasConcept C2780965833 @default.
• W2406393390 hasConcept C71924100 @default.
• W2406393390 hasConcept C90924648 @default.
• W2406393390 hasConceptScore W2406393390C126322002 @default.
• W2406393390 hasConceptScore W2406393390C2775934546 @default.
• W2406393390 hasConceptScore W2406393390C2777391703 @default.
• W2406393390 hasConceptScore W2406393390C2777766500 @default.
• W2406393390 hasConceptScore W2406393390C2778163477 @default.
• W2406393390 hasConceptScore W2406393390C2778270857 @default.
• W2406393390 hasConceptScore W2406393390C2778772119 @default.
• W2406393390 hasConceptScore W2406393390C2779134260 @default.
• W2406393390 hasConceptScore W2406393390C2779306644 @default.
• W2406393390 hasConceptScore W2406393390C2780221984 @default.
• W2406393390 hasConceptScore W2406393390C2780323712 @default.
• W2406393390 hasConceptScore W2406393390C2780965833 @default.
• W2406393390 hasConceptScore W2406393390C71924100 @default.
• W2406393390 hasConceptScore W2406393390C90924648 @default.
• W2406393390 hasIssue "16" @default.
• W2406393390 hasLocation W24063933901 @default.
• W2406393390 hasOpenAccess W2406393390 @default.
• W2406393390 hasPrimaryLocation W24063933901 @default.
• W2406393390 hasRelatedWork W1857149070 @default.
• W2406393390 hasRelatedWork W2033313326 @default.
• W2406393390 hasRelatedWork W2056505063 @default.
• W2406393390 hasRelatedWork W2406393390 @default.
• W2406393390 hasRelatedWork W2590309358 @default.
• W2406393390 hasRelatedWork W2744240433 @default.
• W2406393390 hasRelatedWork W2785954228 @default.
• W2406393390 hasRelatedWork W2808909204 @default.
• W2406393390 hasRelatedWork W3029979019 @default.
• W2406393390 hasRelatedWork W3176138778 @default.
• W2406393390 hasVolume "19" @default.
• W2406393390 isParatext "false" @default.
• W2406393390 isRetracted "false" @default.
• W2406393390 magId "2406393390" @default.
• W2406393390 workType "article" @default.